Lipitor Lawsuit Update: Plaintiffs Seek Consolidation of Federal Cases, Rottenstein Law Group Reports

Plaintiffs in Lipitor lawsuits across the country have petitioned the Judicial Panel on Multidistrict Litigation to consolidate all federal lawsuits for pretrial proceedings, according to court documents, (In re Lipitor (Atorvastatin) Litigation, MDL No. 2459 (JPML)). The Rottenstein Law Group, a national Lipitor law firm, has been monitoring activity in Lipitor lawsuits in federal and state courts across the United States.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Multidistrict litigation allows parties to avoid duplication of efforts, thereby potentially ensuring more efficient pretrial proceedings and the possibility of speedier trials.

(PRWEB) May 01, 2013

Plaintiffs in Lipitor lawsuits across the country have petitioned the Judicial Panel on Multidistrict Litigation to consolidate all federal lawsuits for pretrial proceedings, according to court documents, (In re Lipitor (Atorvastatin) Litigation, MDL No. 2459 (JPML)). The Rottenstein Law Group, a national Lipitor law firm, has been monitoring activity in Lipitor lawsuits in federal and state courts across the United States and offers its insight into the news.

In an April 26 motion, the attorneys for plaintiffs in three federal Lipitor lawsuits petitioned the JPML for the consolidation in the U.S. District Court for the District of South Carolina because the lawsuits all have common questions of fact, including whether drug manufacturer Pfizer knew of the increased risk of diabetes in Lipitor users and whether it failed to adequately warn of that risk, according to court documents.

“Consolidating Lipitor lawsuits such as these could be in the best interests of all parties,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “Multidistrict litigation allows parties to avoid duplication of efforts, thereby potentially ensuring more efficient pretrial proceedings and the possibility of speedier trials.”

Lipitor, a statin, is prescribed to treat high cholesterol. According to research studies, including one published in JAMA: Internal Medicine on January 23, 2012,* there is a potential link between statins such as Lipitor and a Type 2 diabetes risk in women.*

The Rottenstein Law Group, which represents clients in Lipitor lawsuits, operates the Lipitor Lawsuit Information Center. This page on the firm’s website includes a comprehensive look at Lipitor's alleged side effects and how to contact an attorney to determine if Lipitor users have a case.

*archinte.jamanetwork.com/article.aspx?articleid=1108676

About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and drugs. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
http://www.rotlaw.com

                            ###